使用免疫检查点抑制剂治疗的动脉粥样硬化 : 证据 ,诊断,和管理 : JACC : 心脏肿瘤学最新评论。
关键词: ASCVD, atherosclerotic cardiovascular disease CTLA-4, cytotoxic T-lymphocyte associated protein 4 ICI, immune checkpoint inhibitor IFN, interferon IL, interleukin PD-1, programmed cell death protein 1 PD-L1, programmed cell death ligand 1 TNF, tumor necrosis atherosclerosis cardio-oncology cardiovascular disease immune checkpoint inhibitor inflammation irAE, immune-related adverse event
来 源:
DOI:10.1016/j.jaccao.2022.11.011
PDF(Pubmed)